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Papers
Ethnographic study of incidence and severity of
intravenous drug errors
Katja Taxis, Nick Barber
Abstract
Objectives To determine the incidence and clinical
importance of errors in the preparation and
administration of intravenous drugs and the stages of
the process in which errors occur.
Design Prospective ethnographic study using
disguised observation.
Participants Nurses who prepared and administered
intravenous drugs.
Setting 10 wards in a teaching and non-teaching
hospital in the United Kingdom.
Main outcome measures Number, type, and clinical
importance of errors.
Results 249 errors were identified. At least one error
occurred in 212 out of 430 intravenous drug doses
(49%, 95% confidence interval 45% to 54%). Three
doses (1%) had potentially severe errors, 126 (29%)
potentially moderate errors, and 83 (19%) potentially
minor errors. Most errors occurred when giving bolus
doses or making up drugs that required multiple step
preparation.
Conclusions The rate of intravenous drug errors was
high. Although most errors would cause only short
term adverse effects, a few could have been serious. A
combination of reducing the amount of preparation
on the ward, training, and technology to administer
slow bolus doses would probably have the greatest
effect on error rates.
Introduction
Intravenous therapy is a complex healthcare technol-
ogy. In the United Kingdom, as in most other
European countries, nurses generally prepare and
administer intravenous drugs prescribed by doctors.
Administration of intravenous therapy is associated
with considerable risk—for example, patients have died
when cytotoxic drugs have been given intrathecally
instead of intravenously.1 The UK Department of
Health has made this particular type of error one of its
prime targets in increasing patient safety.2 Similar
initiatives have been proposed in the United States.3
Little prospective research has been done into the
incidence, causes, and severity of intravenous drug
errors. Single site studies carried out on one or two
wards have reported errors in preparing and adminis-
tering intravenous drugs of 13%-84%,4–7 but the studies
used different definitions and did not assess the sever-
ity of errors. Epidemiological studies using retrospec-
tive record review have shown that adverse drug events
are common but have not provided detailed analysis of
the type of errors.8–11 We therefore conducted an
ethnographic prospective study using defined meas-
ures to determine the incidence of errors in preparing
and administering intravenous drugs, to identify the
stages in the process in which errors occur, and to
evaluate their clinical importance.
Participants and methods
We used a purposive sampling strategy to select study
hospitals and study wards, with the aim of exploring
the preparation and administration of intravenous
drugs in a range of settings. We selected a university
teaching hospital and a non-teaching general hospital
of similar size (about 20 wards and 400 beds). We did a
pilot study to determine the frequency of use of intra-
venous drugs on each ward and then selected a total of
10 wards with high, medium, and low usage.
Both hospitals operated a typical British ward
pharmacy service. Doctors recorded prescriptions on
formatted inpatient drug charts, and nurses used the
charts to determine the doses due and record the
administration of drugs. Ward pharmacists ordered
drugs that were not stored on the ward and reviewed
the appropriateness of prescribed drugs every
weekday. Nurses usually prepared and administered
intravenous drugs on the wards, but cytotoxic drugs
were prepared centrally by the pharmacy department.
Nurses had to attend a one day training course before
they were allowed to give intravenous drugs. A guide to
preparation and administration of intravenous drugs
was available on each ward.
Identification of errors
We defined an intravenous drug error as a deviation in
preparation or administration of a drug from a
doctor’s prescription, the hospital’s intravenous policy,
or the manufacturer’s instructions. The clinical appro-
priateness of the prescription was not assessed. All
errors had to have the potential to adversely affect the
patient, so deviations from hospital procedures, such as
not checking name bands or not labelling infusions,
were not considered as errors if the correct drug was
given to the patient. Deviations from prescribed
administration time were not considered errors. We
excluded errors if they were corrected by a member of
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staff or the patient before administration. Errors were
related to particular actions; multiple errors could
occur in each case of preparation and administration.
We chose a prospective ethnographic research
method to collect data. A trained and experienced
observer (KT) accompanied nurses during intravenous
drug rounds. She recorded the preparation and
administration of each drug on a standard form. Infor-
mation came from observation and talking informally
to staff. The researcher intervened in a discreet and
non-judgmental manner when she became aware of a
potentially serious error; these incidents were still
included as an error. Ward staff were told that we were
investigating common problems of preparing and
administering intravenous drugs; this disguised obser-
vation method has been shown to be valid.12 The
researcher avoided the word error to prevent the study
from appearing threatening to staff. Each nurse gave
permission for observation.
Data were collected on 6-10 consecutive days on
each ward between June 1999 and December 1999. To
be representative, the study included weekends and all
times of drug rounds on each ward. The researcher
attended two to three drug rounds out of the four that
took place each day.
Importance of errors
We used a validated scale to assess the clinical import-
ance of intravenous drug errors.13 Briefly, four
experienced healthcare professionals (one doctor, one
nurse, and two pharmacists) scored the potential clini-
cal importance of each drug error on a visual analogue
scale between zero (labelled as no harm) and 10
(death). The mean score was calculated for each drug
error. Mean scores below 3 suggested a minor
outcome, scores of 3-7 a moderate outcome, and
scores above 7 a severe outcome.
Analysis of data
The data on the incidence of intravenous drug errors is
expressed in two ways: errors per dose and errors per
process stage (boxes 1 and 2). KT classified the errors
and NB checked them. We calculated proportions and
95% confidence intervals using standard methods.14
Results
A total of 113 nurses and one doctor were observed
over 76 days (table 1). Table 2 shows the number of
observations on each ward. All the nurses agreed to
participate. On three occasions ward managers asked
the researcher not to observe a particular drug round
as the general workload on the ward was high.
Altogether 1042 doses of intravenous drugs, represent-
ing 35 different drugs, were prescribed for 106 patients
during the study. Our observations were representative
for the study period: 41% (430) of all intravenous drug
doses prescribed were observed; administrations of
91% (32) of the prescribed drugs was observed at least
once; and 92% (98) of patients who were prescribed
regular intravenous drugs were observed at least once.
The researcher intervened in 12 cases to prevent an
error reaching the patient.
One or more errors occurred in the preparation
and administration of 212 out of 430 intravenous drug
doses (error rate 49%, 95% confidence interval 45% to
Box 1: Classification of intravenous drug errors
according to stage of occurrence (categories are
mutually exclusive)
Preparation stage
Identification of prescription
Preparation process:
Ready for administration
One step preparation, eg measuring a drug solution
Multiple step preparations, eg measuring and
diluting a drug solution, reconstitution of a drug
Administration stage
Identification of the patient
Administration process:
Bolus dose injection, usually 3 to 5 min
Intermittent infusion
Continuous infusion
Box 2: Classification of type of intravenous
drug errors (categories are mutually exclusive)
Preparation errors
Preparation of wrong drug
Preparation of an unauthorised drug
Errors in solvent/diluent (use of wrong
solvent/diluent or wrong volume)
Preparation of wrong dose
Omission of prescribed drug
Other
Administration errors
Administration to wrong patient
Fast administration of bolus dose through a
peripheral line
Fast administration of bolus dose through a
central line
Incompatibility errors
Other
Table 1 Position of staff included in the study
Staff grade No of observations
Staff nurse 280
Ward manager/sister 73
Bank/agency nurse 62
Student nurse 11
Doctor 4
Total 430
Table 2 Number of observations by type of ward
Type of ward No of observations
University teaching hospital:
General medical ward 41
Renal ward 41
Cardiothoracic surgical ward 42
Coronary intensive care unit 67
Neonatal ward 29
Oncology ward 33
Non-teaching hospital*:
General surgical ward 64
General medical ward 58
Intensive care unit 39
Paediatric ward 16
Total 430
*Former district general hospital.
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54%). A total of 249 errors were identified. Preparation
errors occurred in 32 intravenous doses (7%), adminis-
tration errors in 155 doses (36%), and both types of
error in 25 doses (6%). Errors were potentially severe
in three doses (1%), potentially moderate in 126 (29%),
and potentially minor in 83 (19%). Box 3 describes the
three severe errors and typical examples of moderate
and minor errors.
The figure shows the incidence of errors at each
stage of drug preparation and administration. Most
preparation errors were associated with multiple step
preparations—for example, drugs that required recon-
stitution with a solvent and addition of a diluent. Typi-
cal errors were preparing the wrong dose or selecting
the wrong solvent. All three severe errors occurred at
this stage. A few errors occurred in identifying
prescriptions—for example, not seeing a drug order.
Most errors occurred when giving bolus doses, with
errors in 172/235 (73%) doses. In most of these cases
(163, 95%) the dose was given faster than recom-
mended, which is usually three to five minutes; more
than half of these errors (85, 52%) were considered to
be of potential moderate severity. Table 3 gives a more
detailed analysis of the type and severity of the errors.
Discussion
We found a high incidence of errors in the preparation
and administration of intravenous drugs. Although
most were unlikely to cause lasting harm, some were
serious. The sample was taken from two types of hospi-
tal and included a range of patients, nurses, drugs, drug
administration times, ward specialties, and frequency
of drug administration on the ward. We have used
explicit methods, definitions, and tools that we hope
others can use elsewhere for research and audit.
Although the proportion of serious errors is small,
the number of patients and intravenous doses in a hos-
pital means that errors may be more common than
expected. A point prevalence study we carried out in
the university teaching hospital (400 beds) showed that
about 112 (28%) of inpatients received intravenous
drugs, resulting in more than 300 doses a day.
Although we cannot extrapolate with any precision,
our data suggest that at least one patient will
experience a potentially serious intravenous drug
error every day in a hospital of that size. Hence, intra-
venous drug errors are a potential source of serious
harm for patients and risk reduction strategies should
be developed accordingly.
Reducing the risks
Our analysis shows that the two weak stages in the
system are drugs that require multiple step prepara-
tion and administration of doses as a bolus. Several
strategies could be used to reduce multiple step
preparation errors. Centralised preparation of intra-
venous drugs by the pharmacy department was
suggested in the 1970s in the United Kingdom but
was rarely adopted.15 Centralised preparation of intra-
venous drugs is common in the United States16 but not
in Europe, apart from in specialised areas such as
oncology.17 The evidence for centralised services is
currently weak, and it is unclear whether they are cost
effective or improve the quality of the service.18–21 An
alternative strategy would be to purchase ready
prepared intravenous drugs from pharmaceutical
companies.
The effect of the above changes would have to be
assessed carefully. New types of errors could be
Box 3: Examples of intravenous drug errors
Potentially severe errors
• The whole content of a vial containing 125 000 international units of
heparin was prepared as a continuous infusion, resulting in a five times
overdose (severity score 8.4; general medical ward, teaching hospital).
Comment: Haemorrhage is one of the serious, potentially life threatening
complication of an overdose of heparin.
• A nurse injected 750 mg vancomycin into an infusion bag of 0.9%
sodium chloride (already connected to the patient’s cannula) without
mixing the solution. The patient is likely to have initially received a
concentrated solution of vancomycin as a bolus (severity score 7.3; renal
ward, teaching hospital). Comment: Rapid infusions of vancomycin carry the
risk of reactions such as severe hypotension (including shock and cardiac
arrest) and flushing of the upper body.
• A patient’s continuous infusion of adrenaline (epinephrine) was
interrupted for about 10 minutes as the new infusion had not been
prepared in advance (severity score 7.5; intensive care unit, non-teaching
hospital). Comment: This patient’s blood pressure decreased to about 50/30
mm Hg. A bolus dose of adrenaline and midazolam was given to stabilise
him until the adrenaline infusion was restarted.
Potentially moderate errors
• A nurse measured 0.2 mg metoclopramide using a 1 ml syringe and then
drew up 0.9% sodium chloride into the same syringe. This was administered
as a bolus dose. Using this preparation technique, the metoclopramide
contained in the dead space of the syringe (hub and needle) was also
administered to the patient, resulting in a two to three times overdose
(severity score 7.0; neonatal ward, teaching hospital). Comment: Side effects
include extrapyramidal effects, which are more likely in children. There are
also reports of cardiac conduction abnormalities.
• A patient’s lunchtime dose of 750 mg cefuroxime was omitted because of
his transfer to another ward at lunchtime (severity score 4.1; cardiothoracic
surgical ward, teaching hospital). Comment: Successful anti-infective therapy
depends on achieving effective levels.
• Administration of 80 mg furosemide (frusemide) over 45 seconds
through a peripheral vein (severity score 6.1; general surgical ward,
non-teaching hospital). Comment: The recommended duration of
administration was 20 min (4 mg/min). Tinnitus and deafness are among
the side effects reported after rapid administration.
Potentially minor errors
• Preparation of 1.2 g co-amoxiclav using 10 ml instead of 20 ml water for
injection (severity score 2.3; general surgical ward, non-teaching hospital).
Comment: The drug may not dissolve completely when insufficient solvent is
used. Concentrated solutions may also increase the risk of
thrombophlebitis.
• Administration of 500 mg amoxycillin/10 ml of water by injection over
2.5 minutes rather than through a peripheral vein over 3-5 minutes (severity
score 2.9; general medical ward, teaching hospital). Comment: More rapid
administration may damage the blood vessels but is unlikely in this case.
Identification
of prescription
12/430 (3%) 
Ready for
administration
0/53
One step
preparation
0/32
Multiple step
preparation
50/345 (14%) 
Identification
of patient
0/430
Bolus dose
injection
172/235 (73%) 
Intermittent
infusion
15/163 (9%) 
Continuous
infusion
0/32
Stages and errors in preparation and administration of intravenous drugs (numbers of
errors/number of observations of each stage)
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introduced, such as transmission errors from the ward
to the preparation department.22 Furthermore, nurses
who are no longer used to preparing intravenous
drugs may make serious errors if they have to prepare
drugs in an emergency.
Technical solutions could reduce the frequent errors
from rapid bolus injections—for example, a pump that
prevents fast administration of bolus doses. Staff training
could improve awareness of drugs that have a high risk
of adverse effects when given too fast. A warning could
also be put on the drugs by the pharmacy.
Validity of study
The effect of the observer on the observed is often dis-
cussed as a possible limitation of ethnographic
observation methods.23 The error rate may be even
higher in the absence of the researcher. However, a
previous observation based study using a similar
method showed that the drug error rate is unlikely to
be affected by the observer, even if the observer
occasionally intervenes.12 Modification of behaviour is
minimal once the researcher is an accepted member of
the group and part of the social context.24 The
researcher seemed to have been accepted in our study,
and some initial activities by nurses, such as wearing
gloves to make up the doses, were soon abandoned.
Using an observation based approach allowed us to
explore drugs errors that would not have been
documented and therefore missed by studies relying
on review of hospital records.8 9 11
Conclusions
Our study shows that errors in the preparation and
administration of intravenous drugs remain a concern
in the United Kingdom, 25 years after the problem was
first highlighted. Steps to ensure the correct adminis-
tration of bolus doses and to reduce mistakes in
making up drugs that require multiple step prepara-
tion will have the greatest effect on error rates.
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Table 3 Type and clinical importance of errors in preparation and administration of
intravenous drugs. Values are numbers (percentages) of errors in 430 observations
Type of error*
Importance of error
TotalMinor Moderate Severe
Preparation errors:
Errors in solvent/diluent 20 (5) 16 (4) 0 36 (8)
Wrong dose 0 11 (3) 1 (0.2) 12 (3)
Omission 0 12 (3) 0 12 (3)
Other 0 0 2 (0.5) 2 (0.5)
Administration errors:
Fast bolus dose (peripheral line) 64 (15) 63 (15) 0 127 (30)
Fast bolus dose (central line) 14 (3) 22 (5) 0 36 (8)
Incompatibilities 1 (0.2) 11 (3) 0 12 (3)
Other 3 (7) 9 (2) 0 12 (3)
*No errors were observed in the categories of preparing the wrong drug, using an unauthorised drug, or
administration to the wrong patient.
What is already known on this topic
Errors in preparing and administering
intravenous drugs can cause considerable harm
to patients
Reduction of drug errors is a government health
target in the United Kingdom and the United States
What this study adds
Errors occurred in about half of the intravenous
drug doses observed
Errors were potentially harmful in about a third
of cases
The most common errors were giving bolus doses
too quickly and mistakes in preparing drugs that
required multiple steps
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